Related Articles
Sectors
Sector Update: Financial Stocks Fall Pre-Bell Monday
Financial stocks were falling pre-bell Monday with the State Street Financial Select Sector SPDR ETF (XLF) declining by 0.6%.The Direxion Daily Financial Bull 3X Shares (FAS) was down 1.5% and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was 1.9% higher.BCB Bancorp (BCBP) has appointed veteran banking executive Thomas O'Brien as president and chief executive officer, effective immediately, the company said. BCB Bancorp shares were nearly 1% higher premarket.Barings BDC (BBDC) stock was 0.3% higher after the company said it is terminating the original credit support agreement related to its purchase of Sierra Income.
$BBDC$BCBP$FAS$FAZ$XLF
Sectors
Sector Update: Consumer Stocks Lower Pre-Bell Monday
Consumer stocks were lower pre-bell Monday, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) slipping 0.1% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) down 0.8%.Taylor Morrison Home (TMHC) has agreed to be acquired by Berkshire Hathaway (BRK.A, BRK.B) for $72.50 per share in cash and a total enterprise value of about $8.5 billion, the companies said. Taylor Morrison Home shares were up more than 22% premarket.People Inc. said Monday it has submitted a non-binding proposal to acquire all outstanding MGM Resorts International (MGM) shares it doesn't already own for $48.30 per share in cash. MGM Resorts International stock was advancing past 11% pre-bell.iHuman (IH) agreed to acquire the businesses and assets of two AI-powered apps, All Knowledge and Perfect Lingo, for 94.0 million Chinese renminbi ($13.9 million), the company said. iHuman shares were up more than 2% premarket.
$BRK.A$BRK.B$IH$MGM$TMHC$XLP$XLY
Sectors
Sector Update: Healthcare Stocks Decline Premarket Monday
Healthcare stocks were declining premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.6% and the iShares Biotechnology ETF (IBB) 0.1% lower.Humana (HUM) shares were up more than 4% after the company said it plans to reaffirm its full-year adjusted earnings guidance of at least $9 per share during upcoming meetings.GRAIL's (GRAL) stock was down more than 17% after the company said the NHS-Galleri trial of its Galleri multi-cancer early detection test missed its primary endpoint.Biohaven (BHVN) shares were up more than 1% after the company said it has initiated first-in-human dosing of BHV-8100, an experimental oral, brain-penetrant PKM2 modulator being developed for neurological, retinal and inflammatory diseases.
$BHVN$GRAL$HUM$IBB$XLV